San Diego Business Journal

No Matter How They Are Counted, Local VC Deals Have Slowed

FINANCE: Lackluster Q1 Not a Major Concern As Capital Stays On Sideline By Sarah de Crescenzo Originally published April 24, 2017 at 11:01 a.m., updated April 20, 2017 at 1:06 p.m.

Some of the Biggest VC Deals in San Diego in Q1

• Vividion Therapeutics: $50 million

• Vertiflex Inc.: $40 million

• Biological Dynamics: $28.85 million

• Dauntless Pharmaceuticals: $25 million

• Jecure Therapeutics: $20 million

• Oncternal Therapeutics: $18.40 million

• Genoa Pharmaceuticals: $16.62 million

• Avidity Biosciences:$16 million

• Echo Laboratories: $12.87 million

• Shield AI:$10.5 million

Sources: NCVA based on data from

PitchBook; Dow Jones VentureSource;

PwC/CB Insights MoneyTree


Jeff Grabow

— How hard can it possibly be to track the venture capital raised by local companies?

San Diego is not the Bay Area; quarterly totals have never approached Silicon Valley’s billion-dollar mark and average deal flow is in the dozens, not the hundreds...


Page 1 of 3.

Take 1 minute to subscribe and you’ll get this story immediately, plus:

Already a subscriber? Sign in

  • 51 weekly issues: $153 value
  • Subscriber-only digital content every business day, plus full access to archives: $150 value
  • Book of Lists — the biggest, hottest companies in San Diego: $75 value
  • NEW: San Diego 500 — influential business leaders you need to know: $50 value
  • Total Package Value: $428

Yours for only $129